ArticleNeurology and therapy2019

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Chafké Belmokhtar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.